CD4 and rheumatoid arthritis: A similar capacity to reduce clonal expansions of CD4+ T cells was observed by Pierer et al [18] in 19 RA patients treated with etanercept and in 9 with infliximab, two tumor-necrosis factor alpha (TNFα) blocking agents.